Q2 2019 Holdings
Filed 2019-08-14 | 35 holdings | $604.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $226.8M | 1,970,000 | 37.5% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $181.2M | 2,115,000 | 30.0% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $118.9M | 840,000 | 19.7% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $35.4M | 1,325,000 | 5.9% |
| Allogene Therapeutics Inc(ALLO) | Common | 019770106 | $30.3M | 1,128,594 | 5.0% |
| Adaptive Biotechnologies(ADPT) | Common | 00650F109 | $9.7M | 200,000 | 1.6% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $397.8K | 3,862,500 | 0.1% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $291.3K | 21,000,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $263.7K | 10,752,585 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $212.7K | 1,400,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $145.4K | 7,500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $124.8K | 10,000,000 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $96.8K | 2,025,000 | 0.0% |
| Horizon Therapeutics PLC | Common | G46188101 | $96.2K | 4,000,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | Common | 04269X105 | $92.7K | 2,000,000 | 0.0% |
| Athenex Inc(ATNXEUR) | Common | 04685N103 | $91.2K | 4,605,000 | 0.0% |
| Tricida Inc(1T7) | Common | 89610F101 | $86.8K | 2,200,000 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $68.9K | 1,375,000 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $50.0K | 950,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $41.6K | 3,500,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $37.7K | 360,000 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | Common | 09060J106 | $34.5K | 7,424,867 | 0.0% |
| Medicines Co | Common | 584688105 | $33.7K | 925,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | Common | 69366J200 | $30.8K | 684,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $23.7K | 2,400,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $19.3K | 2,700,000 | 0.0% |
| Pacira Biosciences Inc(PCRX) | Common | 695127100 | $17.4K | 400,000 | 0.0% |
| Kodiak Sciences Inc(KOD) | Common | 50015M109 | $6.8K | 577,021 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $5.6K | 6,240,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | Common | 803607100 | $5.5K | 250,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $4.4K | 1,105,999 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $4.3K | 285,714 | 0.0% |
| Intec Pharma LTD | Common | M53644106 | $3.6K | 820,000 | 0.0% |
| Teligent Inc | Common | 87960W104 | $3.3K | 5,231,206 | 0.0% |
| iShares Russell 2000(IWM)Put | ETF | 464287655 | $110 | 250,000 | 0.0% |